Ilsung Pharmaceuticals Co., Ltd.

KRX:003120.KS

16720 (KRW) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Assets:
Current Assets:
Cash & Cash Equivalents 160,085.707272,920.2950,844.17836,219.7337,278.1641,391.93129,521.9919,872.857,486.4646,072.3657,110.4666,149.6444,551.8356,040.4976,585.1435,006.5455,607.938
Short Term Investments 75,334.48727,010.89413,242.3139,025.35614,688.51352,523.75211,249.32713,887.44163,434.88893,610.06787,725.2290000-855.2970
Cash and Short Term Investments 235,420.194299,931.18464,086.49145,245.08651,966.67853,915.68340,771.31733,760.29170,921.35299,682.43294,835.6956,149.6444,551.8356,040.4976,585.1435,006.5455,607.938
Net Receivables 24,790.55823,333.195203,371.245204,829.02206,206.323209,783.591215,015.997216,300.922212,825.82225,467.879026,674.66418,877.811024,490.577026,036.164
Inventory 31,240.77920,641.29512,478.26613,132.37814,147.00915,386.04823,022.72220,109.53417,856.8917,688.84220,130.11317,870.02821,376.28320,452.56325,542.7817,964.60215,840.553
Other Current Assets 2,491.586028.89841.709120.811336.41-0-0-0-023,401.3290.001-020,504.342-0.00126,138.4810.002
Total Current Assets 293,943.117343,905.674279,964.9263,248.192272,440.82279,421.732278,810.035270,170.748301,604.064142,839.153138,367.13650,694.33744,805.92946,997.40256,618.49949,109.62847,484.657
Non-Current Assets:
Property, Plant & Equipment, Net 69,750.30192,649.32533,111.58526,038.45824,110.92325,678.40127,087.3628,513.95428,954.16728,406.87430,077.58631,922.82634,373.68833,207.69731,833.79629,845.29831,543.414
Goodwill 000000000184.703184.703184.703184.703169.311000
Intangible Assets 2,378.1362,290.5031,918.984278.914303.245327.575218.088223.588372.701529.435654.668884.7351,084.154454.568576.32539.80234.674
Goodwill and Intangible Assets 2,378.1362,290.5031,918.984278.914303.245327.575218.088223.588372.701714.138839.3711,069.4381,268.857623.879576.32539.80234.674
Long Term Investments 51,411.34925,388.39840,500.79171,887.53254,490.329-11,169.52630,096.90125,706.229-27,337.489112,800.471115,650.0340000208,859.2620
Tax Assets 5.092015,886.2429,771.41918,170.86253,006.25111,249.3270093,610.06787,725.22900117.94579.20360.134400.098
Other Non-Current Assets 1,701.93430,186.198-00-0.001-0-013,887.44163,434.888-00299,938.818332,743.637388,461.795278,220.178-0.001414,625.794
Total Non-Current Assets 125,246.813150,514.42491,417.601107,976.32397,075.35867,842.70168,651.67568,331.21265,424.267235,531.55234,292.22332,931.083368,386.182422,411.316310,709.502238,804.495446,603.98
Total Assets 419,189.929494,420.098371,382.501371,224.516369,516.179347,264.433347,461.71338,501.96367,028.331378,370.702372,659.356383,625.419413,192.111469,408.717367,328.001287,914.123494,088.637
Liabilities & Equity:
Current Liabilities:
Account Payables 5,763.5575,050.468758.2752,100.1152,328.8712,322.2045,286.4661,273.3441,570.11,841.5375,175.1894,362.2534,218.5182,353.2424,775.6484,753.3992,403.598
Short Term Debt 118.44892.544171.548311.12-9.4530000001,5003,5005,0003,00000
Tax Payables 204.47129,652.6261,572.762292.6233,159.2381,755.6581,471.4011,800.97832,147.6412,426.367885.2897,386.49610,514.7451,380.9512,121.96511,066.6094,584.578
Deferred Revenue 2017,624.94612,437.4239.4530000007,386.49610,514.7455,462.7665,249.43500
Other Current Liabilities 29,008.10737,414.932,172.2251,975.63315,987.19213,582.05710,224.9267,844.04437,291.1217,169.0144,480.76410,847.0153,616.871-0.0010.00113,684.1288,876.907
Total Current Liabilities 34,892.11242,557.94220,726.99416,824.29118,316.06315,904.26115,511.3929,117.38838,861.2229,010.5519,655.95324,095.76521,850.13412,816.00713,025.08418,437.52711,280.505
Non-Current Liabilities:
Long Term Debt 119.678181.8079.52130.384126.501000000002,804.683000
Deferred Revenue Non-Current 900.8331,135.8331,370.8331,527.5404.93100000004,617.183,347.1000
Deferred Tax Liabilities Non-Current 04,977.3073,365.5635,218.9965,179.2316,030.7386,909.7286,759.8217,302.8738,429.237,938.8338,159.48351,715.16771,344.75539,846.73520,940.87279,951.488
Other Non-Current Liabilities 523.6260047.252-0994.3842,214.362,523.9252,521.6542,248.3942,320.393,311.1753,305.032-0.0012,772.4572,059.1552,823.282
Total Non-Current Liabilities 1,544.1386,294.9474,745.9166,924.1315,710.6637,025.1239,124.0889,283.7469,824.52540,677.59440,259.2241,470.65859,637.37977,496.53742,619.19223,000.02782,774.77
Total Liabilities 36,436.24948,852.88925,472.9123,748.42324,026.72622,929.38424,635.4818,401.13448,685.74649,688.14549,915.17365,566.42281,487.51490,312.54555,644.27641,437.55494,055.275
Equity:
Preferred Stock 0000000072,616.23200000000
Common Stock 13,30013,30013,30013,30013,30013,30013,30013,30013,30013,30013,30013,30013,30013,30013,30013,30013,300
Retained Earnings 55,328.231506,894.168402,810.463404,579.631398,948.641393,646.003393,890.783392,471.888390,998.208293,012.773289,508.258281,800.046246,357.278209,844.042204,462.41197,408.31164,556.034
Accumulated Other Comprehensive Income/Loss 403,708.692400,799.702402,877.086400,554.42395,659.769408,398.727408,544.126405,627.618-72,616.23200000000
Other Total Stockholders Equity -89,583.243-475,426.661-473,077.957-470,957.958-462,418.958-491,009.68-492,908.679-491,298.68-85,955.62322,369.78419,935.92522,958.9572,047.32155,952.1393,921.31535,768.259222,177.327
Total Shareholders Equity 382,753.68445,567.209345,909.591347,476.093345,489.453324,335.049322,826.23320,100.826318,342.584328,682.557322,744.183318,058.997331,704.598379,096.172311,683.725246,476.569400,033.361
Total Equity 382,753.68445,567.209345,909.591347,476.093345,489.453324,335.049322,826.23320,100.826318,342.584328,682.557322,744.183318,058.997331,704.598379,096.172311,683.725246,476.569400,033.361
Total Liabilities & Shareholders Equity 419,189.929494,420.098371,382.501371,224.516369,516.179347,264.433347,461.71338,501.96367,028.331378,370.702372,659.356383,625.419413,192.111469,408.717367,328.001287,914.123494,088.636